Yunnan Botanee Bio-Technology Group Co., Ltd.

Yunnan Botanee Bio-Technology Group Co., Ltd. saw a notable increase today, reaching an intraday high. However, the company has faced a decline over the past week and a significant drop over the past year. Financial metrics indicate challenges, including negative results for six consecutive quarters.

Yunnan Botanee Bio-Technology Group Co., Ltd. has faced a notable decline in its stock performance, with significant drops over various time frames. Financial metrics indicate challenges, including a substantial decrease in net profit and sales, alongside a high price-to-book ratio, reflecting ongoing difficulties in the FMCG sector.

Yunnan Botanee Bio-Technology Group Co., Ltd. has faced a notable decline in its stock performance, with significant drops over various time frames. The company has reported negative growth in net sales and profits, alongside a low return on equity and high price-to-book ratio, indicating ongoing financial challenges.

Yunnan Botanee Bio-Technology Group Co., Ltd. saw a significant stock decline today, underperforming against the China Shanghai Composite. The company reported a net profit decrease of 34.99% and a drop in net sales by 13.88%. Its three-year performance reflects ongoing challenges in maintaining market position.

Yunnan Botanee Bio-Technology Group Co., Ltd. saw a significant stock decline today, contrasting with the broader market. The company has faced ongoing financial challenges, including negative growth in net sales and operating profit over five years, and has reported losses for six consecutive quarters.

Yunnan Botanee Bio-Technology Group Co., Ltd. faced a significant stock decline today, contrasting with the broader market's performance. The company reported a substantial drop in net profit and sales in its latest half-year results, alongside a notable long-term underperformance compared to market benchmarks.